Skip to main content
. 2023 Apr 20;12(13):13894–13911. doi: 10.1002/cam4.5930

FIGURE 2.

FIGURE 2

Forest plots of the objective response rates (ORRs) and disease control rates (DCRs). (A). Overall pooled ORR of the 45 studies indicated high heterogeneity for the ORR of advanced uterine leiomyosarcoma patients. (B) Overall pooled DCR of 48 studies of advanced uterine leiomyosarcoma (uLMS). Heterogeneity is the variability between the study‐specific effects that a random variation cannot explain. CI, confidence interval.